Complete remission of a high risk metastatic rhabdomyosarcoma in an adolescent treated with a liposomal (Myocet) regimen
Archive of Clinical Cases · 2014
DOI: 10.22551/2014.02.0102.10012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archive of Clinical Cases, 2014. Verfasst von Aurelie Phulpin-Weibel und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
We report the case of a very high risk metastatic rhabdomyosarcoma teenager treated with an induction therapy using only liposomal doxorubicin (Myocet®) because of his extremely bad health condition. A near complete remission was obtained after 2 courses. Then he received conventional chemotherapy according to the EpSSG protocol, radiotherapy and a reduced-intensity conditioning regimen followed by pheno-identical allogeneic stem cell transplantation. He is in continuous complete remission with a follow-up of nine years.
Zitieren
APA
Phulpin-Weibel, A., Mansuy, L., Bernier-Chastagner, V., Galloy, M., Bordigoni, P., & Chastagner, P. (2014). Complete remission of a high risk metastatic rhabdomyosarcoma in an adolescent treated with a liposomal (Myocet) regimen. Archive of Clinical Cases. https://doi.org/10.22551/2014.02.0102.10012
Vancouver
Phulpin-Weibel A, Mansuy L, Bernier-Chastagner V, Galloy M, Bordigoni P, Chastagner P. Complete remission of a high risk metastatic rhabdomyosarcoma in an adolescent treated with a liposomal (Myocet) regimen. Archive of Clinical Cases. 2014. doi:10.22551/2014.02.0102.10012
BibTeX
@article{PhulpinWeibel2014,
author = {Phulpin-Weibel, Aurelie and Mansuy, Ludovic and Bernier-Chastagner, Valerie and Galloy, Marie-Agnes and Bordigoni, Pierre and Chastagner, Pascal},
title = {Complete remission of a high risk metastatic rhabdomyosarcoma in an adolescent treated with a liposomal (Myocet) regimen},
journal = {Archive of Clinical Cases},
year = {2014},
doi = {10.22551/2014.02.0102.10012}
}
EUVIMED